Tamoxifen treatment and pulmunary embolism: a case report and literature review

Submitted: November 25, 2015
Accepted: November 25, 2015
Published: November 25, 2015
Abstract Views: 1147
PDF: 1182
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Zanini, Gregoriana, Benedetta Fontanella, Marco Racheli, Monica Bortolotti, and Gianfranco Pasini. 2015. “Tamoxifen Treatment and Pulmunary Embolism: A Case Report and Literature Review”. Monaldi Archives for Chest Disease 80 (1). https://doi.org/10.4081/monaldi.2013.91.